Recent Press Releases

Medidata and TransCelerate BioPharma Inc. Announce Findings of Joint Research Initiative on Clinical Trial Site Monitoring Methods

NEW YORK--Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced the results of a data-driven analysis conducted in...

PRA Health Sciences, Inc. Announces Successful Closing of its Initial Public Offering

RALEIGH, N.C. -- PRA Health Sciences, Inc. (PRAH) ("PRA") today announced the closing of its initial public offering of its common stock. Shares of PRA began trading on the Nasdaq Global...

INC Research Announces Closing of Initial Public Offering

RALEIGH, N.C. -- INC Research Holdings, Inc. (INC Research) (INCR), a leading, global Phase I to IV contract research organization, today announced the closing of its previously announced initial...

NextDocs Joins the PAREXEL Perceptive® Partner Program to Expand Enterprise Content Management Footprint in Life Sciences

CONSHOHOCKEN, Pa., Nov. 17, 2014 /PRNewswire/ -- NextDocs Corporation, a leading provider of regulated content management and compliance solutions for the life sciences industry, today announced the...

AMRI ANNOUNCES ALBUQUERQUE, N.M. MANUFACTURING FACILITY FULLY OPERATIONAL

ALBUQUERQUE, N.M. -- AMRI (NASDAQ: AMRI) today announced that its Albuquerque, N.M. sterile injectable facility has resumed full manufacturing operations. As previously announced, in September 2014...

Ricerca Biosciences, LLC Acquired By Growth-Oriented Equity Investment Group

CONCORD, Ohio -- A northeast-Ohio based investment fund has acquired the parent company of Ricerca Biosciences, LLC on November 14, 2014. After conducting a thorough process to evaluate strategic...

STATKING Clinical Services Reaches 25 Year Milestone

Cincinnati, OH – November 18, 2014 – STATKING Clinical Services (SCS), a privately-owned, Cincinnati-based Contract Research Organization (CRO), has observed its 25th anniversary of...

Recipharm AB: Recipharm Acquires Lusomedicamenta for SEK 1 Billion

STOCKHOLM--()--Regulatory News: The Pharmaceutical Contract Development and Manufacturing Organisation, Recipharm AB (publ)(STO:RECI) has acquired Lisbon based CDMO Lusomedicameta...

PAREXEL Expands Clinical Trial Supply And Logistics Services Through Opening Of New European Coordination Hub and Distribution Center

BOSTON -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the opening of its new European Coordination Hub and Distribution...

Catalent Reports First Quarter Fiscal Year 2015 Results

Total revenue increased 1%, both as-reported and in constant currency, to $418.3 million from first quarter 2014 Adjusted EBITDA increased 2% to $83.4 million from first quarter 2014 Adjusted...

Catalent Adds Global Particle Size Technology Leader To Industry's Broadest Bioavailability And Delivery Technology Offerings

Somerset, N.J. – November 13, 2014 — Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer...

WuXi PharmaTech Announces Third-Quarter 2014 Results

SHANGHAI -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device...

Catalent Expands Highly Potent And Cytotoxic Clinical Packaging Capabilities At Kansas City Campus

Somerset, N.J. — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has today...

inVentiv Health Names Jeffrey Wilks as President of Advertising

NEW YORK -- inVentiv Health, Inc. ("inVentiv"), a life science knowledge and services company for the new healthcare environment, today announced the appointment of Jeffrey Wilks as...

GVK BIO Signs Definitive Agreement to Acquire Vanta Bioscience

HYDERABAD, India--Asia's leading Discovery Research and Development organization, GVK BIO, announced the signing of a definitive agreement to acquire Vanta Bioscience, a full service preclinical...

ICON Selected by the FDA to Develop New Patient-Reported Outcome Measure for Hospital-Acquired Bacterial Pneumonia Trials

DUBLIN--ICON plc, (NASDAQ: ICLR) a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been awarded a...

Charles River's Early Drug Discovery Business and CHDI Foundation Extend Huntington's Disease Collaboration

WILMINGTON, Mass.--Charles River Laboratories International, Inc. announced today that CHDI Foundation, Inc. has extended its ongoing collaboration for an additional five years through 2019. The...

Medidata and PPD Partner to Offer New Approach to Risk-Based Monitoring

NEW YORK--Medidata (NASDAQ:MDSO), a leading global provider of cloud-based solutions for clinical research in life sciences, and Pharmaceutical Product Development, LLC (PPD), a global contract...

AMRI Announces Third Quarter 2014 Results

- Third quarter contract revenue of $57.5 million, up 8% from 2013 - Lower Discovery and API revenue is offset by addition of OsoBio - OsoBio business interruption contributes to third quarter...

Chiltern is Designed Around You

LONDON and WILMINGTON, N.C., Nov. 3, 2014 -- With a renewed therapeutic specialization, deepened service offering and expanded geographic footprint, Chiltern launches today as a completely integrated...